CN Stock MarketDetailed Quotes

Cofoe Medical Technology (301087)

Watchlist
  • 57.50
  • +0.30+0.52%
Market Closed Apr 17 15:00 CST
12.01BMarket Cap32.32P/E (TTM)

Cofoe Medical Technology (301087) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
13.56%3.39B
6.63%2.4B
-4.03%1.5B
-8.59%737.79M
4.53%2.98B
5.87%2.25B
2.60%1.56B
-5.64%807.15M
-4.14%2.85B
13.11%2.12B
Operating revenue
13.56%3.39B
6.63%2.4B
-4.03%1.5B
-8.59%737.79M
4.53%2.98B
5.87%2.25B
2.60%1.56B
-5.64%807.15M
-4.14%2.85B
13.11%2.12B
Other operating revenue
-3.91%135.86M
----
-29.93%48M
----
-4.49%141.38M
----
12.08%68.5M
----
37.00%148.02M
----
Total operating cost
15.52%3.04B
8.52%2.14B
-1.37%1.32B
-4.50%646.33M
1.40%2.63B
5.68%1.97B
3.76%1.34B
-0.02%676.81M
-1.96%2.59B
7.31%1.87B
Operating cost
10.48%1.59B
2.30%1.12B
-7.56%710.64M
-12.85%352.89M
-11.28%1.44B
-5.79%1.09B
-6.19%768.79M
-3.05%404.95M
-10.11%1.62B
0.03%1.16B
Operating tax surcharges
39.43%36.65M
35.83%26.14M
22.86%16.22M
4.08%7.19M
-8.83%26.29M
-12.00%19.24M
21.31%13.21M
11.88%6.9M
46.46%28.83M
104.84%21.87M
Operating expense
18.99%1.16B
14.64%815.84M
2.90%480.22M
4.53%228.42M
31.40%973.31M
35.49%711.66M
31.99%466.69M
11.55%218.53M
19.62%740.7M
20.98%525.23M
Administration expense
42.57%173.08M
28.71%123.18M
31.36%80.36M
37.52%40.6M
9.44%121.39M
4.17%95.7M
-1.62%61.17M
-8.71%29.52M
-8.78%110.92M
6.84%91.87M
Financial expense
86.91%-2.99M
77.05%-3.77M
75.97%-3.1M
70.58%-1.61M
-19.76%-22.83M
-37.71%-16.44M
-73.62%-12.91M
-16.89%-5.46M
42.74%-19.06M
45.06%-11.94M
-Interest expense (Financial expense)
-10.31%16.07M
-16.04%11.01M
-14.06%7.31M
5.31%2.87M
32.66%17.91M
90.62%13.12M
-1.53%8.51M
3.10%2.72M
24.45%13.5M
-13.28%6.88M
-Interest Income (Financial expense)
37.62%-26.43M
43.19%-18.28M
44.71%-12.2M
38.07%-5.9M
-23.50%-42.37M
-35.89%-32.18M
-30.31%-22.07M
-6.35%-9.53M
25.25%-34.31M
33.72%-23.68M
Research and development
-9.47%87.28M
-11.98%61.09M
-12.61%40.05M
-15.79%18.84M
-15.67%96.41M
-12.41%69.41M
-17.32%45.83M
-24.18%22.37M
-3.46%114.33M
12.77%79.24M
Credit Impairment Loss
59.39%-2.01M
69.59%-1.15M
55.68%-1.19M
28.60%-2.21M
-502.84%-4.95M
-179.07%-3.77M
-159.62%-2.69M
-145.78%-3.1M
94.43%-821.15K
222.24%4.77M
Asset Impairment Loss
5.89%-31.81M
12.39%-27.75M
-16.86%-30.93M
-14.58%-24.57M
35.22%-33.8M
37.50%-31.68M
34.01%-26.47M
36.29%-21.44M
-12.69%-52.18M
-159.70%-50.68M
Other net revenue
282.06%80.35M
137.16%44.96M
2,188.50%25.71M
264.52%18.2M
-40.62%21.03M
-20.19%18.96M
-112.42%-1.23M
46.94%-11.06M
-6.15%35.42M
-56.54%23.75M
Fair value change income
430.24%49.84M
457.76%13.89M
529.86%10.98M
-3.29%7.29M
701.54%9.4M
-92.54%2.49M
-111.62%-2.55M
-25.28%7.54M
-135.50%-1.56M
-2.33%33.36M
Invest income
28.38%15.84M
20.86%18.18M
10.12%14.39M
2,492.20%10.33M
-74.13%12.34M
1,485.88%15.04M
61,756.89%13.07M
-3,528.76%-431.7K
-15.92%47.72M
-45.93%948.55K
-Including: Investment income associates
122.26%778.63K
195.75%1.37M
731.93%643.14K
164.21%277.17K
-2,585.70%-3.5M
624.05%462.02K
-58.56%-101.77K
-3,528.76%-431.7K
-519.85%-130.24K
-212.02%-88.16K
Asset deal income
-123.29%-1.37M
-1,191.60%-695.66K
-744.09%-579.01K
38.52%87.56K
28.05%5.88M
-101.10%-53.86K
-96.27%89.9K
-30.74%63.21K
-29.07%4.59M
50.97%4.88M
Other revenue
55.02%49.86M
15.05%42.48M
90.71%33.03M
332.64%27.28M
-14.63%32.16M
21.19%36.93M
-18.04%17.32M
61.76%6.31M
20.89%37.68M
-21.70%30.47M
Operating profit
14.93%429.04M
2.39%301.81M
-8.17%197.08M
-8.06%109.67M
26.66%373.3M
4.92%294.75M
-8.64%214.6M
-24.30%119.28M
-20.00%294.73M
45.60%280.94M
Add:Non operating Income
-33.41%4.18M
40.04%5.9M
17.56%4.76M
63.62%799.96K
1,545.28%6.28M
2,038.69%4.21M
2,772.25%4.05M
377.61%488.9K
-13.00%381.6K
-40.90%196.91K
Less:Non operating expense
-2.65%7.38M
-11.87%3.53M
-13.36%2.18M
1.58%1.04M
-19.34%7.58M
-17.11%4.01M
-33.65%2.52M
-51.77%1.02M
-72.71%9.4M
71.12%4.83M
Total profit
14.47%425.84M
3.13%304.18M
-7.62%199.66M
-7.85%109.43M
30.20%372M
6.75%294.96M
-6.54%216.14M
-23.66%118.74M
-14.56%285.71M
45.07%276.3M
Less:Income tax cost
-6.92%55.53M
3.83%44.67M
5.04%33.02M
0.85%17.85M
81.67%59.66M
26.81%43.02M
-0.27%31.43M
-20.14%17.7M
1.45%32.84M
58.63%33.92M
Net profit
18.56%370.32M
3.00%259.51M
-9.78%166.64M
-9.37%91.57M
23.52%312.34M
3.94%251.94M
-7.52%184.7M
-24.24%101.04M
-16.27%252.87M
43.36%242.38M
Net profit from continuing operation
18.56%370.32M
3.00%259.51M
-9.78%166.64M
-9.37%91.57M
23.52%312.34M
3.94%251.94M
-7.52%184.7M
-24.24%101.04M
-16.27%252.87M
43.36%242.38M
Less:Minority Profit
-318.08%-1.29M
-3,432.30%-709.66K
-172.36%-744.61K
180.92%147.73K
142.05%592.61K
-94.94%21.3K
-133.26%-273.39K
83.99%-182.55K
-519.18%-1.41M
-73.48%420.61K
Net profit of parent company owners
19.20%371.61M
3.30%260.22M
-9.51%167.39M
-9.68%91.43M
22.60%311.75M
4.12%251.92M
-7.00%184.98M
-24.75%101.22M
-15.71%254.28M
44.47%241.96M
Earning per share
Basic earning per share
19.61%1.83
3.23%1.28
-9.89%0.82
-10.00%0.45
23.39%1.53
6.90%1.24
-4.21%0.91
-23.08%0.5
-14.48%1.24
45.00%1.16
Diluted earning per share
19.87%1.81
3.25%1.27
-10.00%0.81
-8.16%0.45
21.77%1.51
6.03%1.23
-5.26%0.9
-24.62%0.49
-14.48%1.24
45.00%1.16
Other composite income
-1.77M
643.59K
Other composite income of parent company owners
---1.55M
--563.78K
----
----
----
----
----
----
----
----
Other composite income of minority owners
---219.22K
--79.81K
----
----
----
----
----
----
----
----
Total composite income
17.99%368.55M
3.26%260.15M
-9.78%166.64M
-9.37%91.57M
23.52%312.34M
3.94%251.94M
-7.52%184.7M
-24.24%101.04M
-16.27%252.87M
43.36%242.38M
Total composite income of parent company owners
18.70%370.06M
3.52%260.78M
-9.51%167.39M
-9.68%91.43M
22.60%311.75M
4.12%251.92M
-7.00%184.98M
-24.75%101.22M
-15.71%254.28M
44.47%241.96M
Total composite income of minority owners
-355.08%-1.51M
-3,057.53%-629.84K
-172.36%-744.61K
180.92%147.73K
142.05%592.61K
-94.94%21.3K
-133.26%-273.39K
83.99%-182.55K
-519.18%-1.41M
-73.48%420.61K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue 13.56%3.39B6.63%2.4B-4.03%1.5B-8.59%737.79M4.53%2.98B5.87%2.25B2.60%1.56B-5.64%807.15M-4.14%2.85B13.11%2.12B
Operating revenue 13.56%3.39B6.63%2.4B-4.03%1.5B-8.59%737.79M4.53%2.98B5.87%2.25B2.60%1.56B-5.64%807.15M-4.14%2.85B13.11%2.12B
Other operating revenue -3.91%135.86M-----29.93%48M-----4.49%141.38M----12.08%68.5M----37.00%148.02M----
Total operating cost 15.52%3.04B8.52%2.14B-1.37%1.32B-4.50%646.33M1.40%2.63B5.68%1.97B3.76%1.34B-0.02%676.81M-1.96%2.59B7.31%1.87B
Operating cost 10.48%1.59B2.30%1.12B-7.56%710.64M-12.85%352.89M-11.28%1.44B-5.79%1.09B-6.19%768.79M-3.05%404.95M-10.11%1.62B0.03%1.16B
Operating tax surcharges 39.43%36.65M35.83%26.14M22.86%16.22M4.08%7.19M-8.83%26.29M-12.00%19.24M21.31%13.21M11.88%6.9M46.46%28.83M104.84%21.87M
Operating expense 18.99%1.16B14.64%815.84M2.90%480.22M4.53%228.42M31.40%973.31M35.49%711.66M31.99%466.69M11.55%218.53M19.62%740.7M20.98%525.23M
Administration expense 42.57%173.08M28.71%123.18M31.36%80.36M37.52%40.6M9.44%121.39M4.17%95.7M-1.62%61.17M-8.71%29.52M-8.78%110.92M6.84%91.87M
Financial expense 86.91%-2.99M77.05%-3.77M75.97%-3.1M70.58%-1.61M-19.76%-22.83M-37.71%-16.44M-73.62%-12.91M-16.89%-5.46M42.74%-19.06M45.06%-11.94M
-Interest expense (Financial expense) -10.31%16.07M-16.04%11.01M-14.06%7.31M5.31%2.87M32.66%17.91M90.62%13.12M-1.53%8.51M3.10%2.72M24.45%13.5M-13.28%6.88M
-Interest Income (Financial expense) 37.62%-26.43M43.19%-18.28M44.71%-12.2M38.07%-5.9M-23.50%-42.37M-35.89%-32.18M-30.31%-22.07M-6.35%-9.53M25.25%-34.31M33.72%-23.68M
Research and development -9.47%87.28M-11.98%61.09M-12.61%40.05M-15.79%18.84M-15.67%96.41M-12.41%69.41M-17.32%45.83M-24.18%22.37M-3.46%114.33M12.77%79.24M
Credit Impairment Loss 59.39%-2.01M69.59%-1.15M55.68%-1.19M28.60%-2.21M-502.84%-4.95M-179.07%-3.77M-159.62%-2.69M-145.78%-3.1M94.43%-821.15K222.24%4.77M
Asset Impairment Loss 5.89%-31.81M12.39%-27.75M-16.86%-30.93M-14.58%-24.57M35.22%-33.8M37.50%-31.68M34.01%-26.47M36.29%-21.44M-12.69%-52.18M-159.70%-50.68M
Other net revenue 282.06%80.35M137.16%44.96M2,188.50%25.71M264.52%18.2M-40.62%21.03M-20.19%18.96M-112.42%-1.23M46.94%-11.06M-6.15%35.42M-56.54%23.75M
Fair value change income 430.24%49.84M457.76%13.89M529.86%10.98M-3.29%7.29M701.54%9.4M-92.54%2.49M-111.62%-2.55M-25.28%7.54M-135.50%-1.56M-2.33%33.36M
Invest income 28.38%15.84M20.86%18.18M10.12%14.39M2,492.20%10.33M-74.13%12.34M1,485.88%15.04M61,756.89%13.07M-3,528.76%-431.7K-15.92%47.72M-45.93%948.55K
-Including: Investment income associates 122.26%778.63K195.75%1.37M731.93%643.14K164.21%277.17K-2,585.70%-3.5M624.05%462.02K-58.56%-101.77K-3,528.76%-431.7K-519.85%-130.24K-212.02%-88.16K
Asset deal income -123.29%-1.37M-1,191.60%-695.66K-744.09%-579.01K38.52%87.56K28.05%5.88M-101.10%-53.86K-96.27%89.9K-30.74%63.21K-29.07%4.59M50.97%4.88M
Other revenue 55.02%49.86M15.05%42.48M90.71%33.03M332.64%27.28M-14.63%32.16M21.19%36.93M-18.04%17.32M61.76%6.31M20.89%37.68M-21.70%30.47M
Operating profit 14.93%429.04M2.39%301.81M-8.17%197.08M-8.06%109.67M26.66%373.3M4.92%294.75M-8.64%214.6M-24.30%119.28M-20.00%294.73M45.60%280.94M
Add:Non operating Income -33.41%4.18M40.04%5.9M17.56%4.76M63.62%799.96K1,545.28%6.28M2,038.69%4.21M2,772.25%4.05M377.61%488.9K-13.00%381.6K-40.90%196.91K
Less:Non operating expense -2.65%7.38M-11.87%3.53M-13.36%2.18M1.58%1.04M-19.34%7.58M-17.11%4.01M-33.65%2.52M-51.77%1.02M-72.71%9.4M71.12%4.83M
Total profit 14.47%425.84M3.13%304.18M-7.62%199.66M-7.85%109.43M30.20%372M6.75%294.96M-6.54%216.14M-23.66%118.74M-14.56%285.71M45.07%276.3M
Less:Income tax cost -6.92%55.53M3.83%44.67M5.04%33.02M0.85%17.85M81.67%59.66M26.81%43.02M-0.27%31.43M-20.14%17.7M1.45%32.84M58.63%33.92M
Net profit 18.56%370.32M3.00%259.51M-9.78%166.64M-9.37%91.57M23.52%312.34M3.94%251.94M-7.52%184.7M-24.24%101.04M-16.27%252.87M43.36%242.38M
Net profit from continuing operation 18.56%370.32M3.00%259.51M-9.78%166.64M-9.37%91.57M23.52%312.34M3.94%251.94M-7.52%184.7M-24.24%101.04M-16.27%252.87M43.36%242.38M
Less:Minority Profit -318.08%-1.29M-3,432.30%-709.66K-172.36%-744.61K180.92%147.73K142.05%592.61K-94.94%21.3K-133.26%-273.39K83.99%-182.55K-519.18%-1.41M-73.48%420.61K
Net profit of parent company owners 19.20%371.61M3.30%260.22M-9.51%167.39M-9.68%91.43M22.60%311.75M4.12%251.92M-7.00%184.98M-24.75%101.22M-15.71%254.28M44.47%241.96M
Earning per share
Basic earning per share 19.61%1.833.23%1.28-9.89%0.82-10.00%0.4523.39%1.536.90%1.24-4.21%0.91-23.08%0.5-14.48%1.2445.00%1.16
Diluted earning per share 19.87%1.813.25%1.27-10.00%0.81-8.16%0.4521.77%1.516.03%1.23-5.26%0.9-24.62%0.49-14.48%1.2445.00%1.16
Other composite income -1.77M643.59K
Other composite income of parent company owners ---1.55M--563.78K--------------------------------
Other composite income of minority owners ---219.22K--79.81K--------------------------------
Total composite income 17.99%368.55M3.26%260.15M-9.78%166.64M-9.37%91.57M23.52%312.34M3.94%251.94M-7.52%184.7M-24.24%101.04M-16.27%252.87M43.36%242.38M
Total composite income of parent company owners 18.70%370.06M3.52%260.78M-9.51%167.39M-9.68%91.43M22.60%311.75M4.12%251.92M-7.00%184.98M-24.75%101.22M-15.71%254.28M44.47%241.96M
Total composite income of minority owners -355.08%-1.51M-3,057.53%-629.84K-172.36%-744.61K180.92%147.73K142.05%592.61K-94.94%21.3K-133.26%-273.39K83.99%-182.55K-519.18%-1.41M-73.48%420.61K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Ernst & Young Huaming Accounting Firm (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More